Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-small Cell Lung Cancer Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04844073
What this trial is testing

TAK-186 (Also Known as MVC-101) in Adults With Advanced or Metastatic Cancer

Who this might be right for
Squamous Cell Cancer of Head and Neck (SCCHN)Non-small Cell Lung Cancer (NSCLC)Colorectal Cancer
Takeda 95
Not applicableStudy completedNCT01136083
What this trial is testing

Effect of Exercise Training on Angiogenesis and Cachexia in Lung Cancer Patients

Who this might be right for
Non-small-cell Lung Cancer
National Taiwan University Hospital 60
Testing effectiveness (Phase 2)Study completedNCT00948961
What this trial is testing

CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1

Who this might be right for
Advanced Malignancies
Celldex Therapeutics 70
Not applicableStudy completedNCT01067794
What this trial is testing

Chemotherapy in Treating Patients With Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Eli Lilly and Company 1,610
Testing effectiveness (Phase 2)UnknownNCT05468294
What this trial is testing

F16IL2 in Combination With Nivolumab in Patients With Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Philogen S.p.A. 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT04392505
What this trial is testing

Durvalumab(MEDI4736) After chemoRadioTherapy(DART) for NSCLC-a Translational and Biomarker Study

Who this might be right for
CancerNon Small Cell Lung CancerNon Small Cell Lung Cancer Stage III+2 more
Oslo University Hospital 100
Early research (Phase 1)Ended earlyNCT00288054
What this trial is testing

S0429: Docetaxel, Cetuximab, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
SWOG Cancer Research Network 24
Not applicableEnded earlyNCT01137162
What this trial is testing

Clinical and Pathologic Studies of Patients Undergoing Treatment With EGFR Inhibitors

Who this might be right for
Anal, Colon, and Rectal CancersHead and Neck CancerLung Cancer+17 more
Stanford University 10
Not applicableUnknownNCT03956641
What this trial is testing

Evolution of the Physical Condition in Treated Cancer Patients

Who this might be right for
Non-small Cell Lung Cancer MetastaticBreast Cancer FemaleColon Cancer
Centre Paul Strauss 300
Large-scale testing (Phase 3)UnknownNCT04033354
What this trial is testing

A Randomized, Double-blind, Placebo Controlled Phase III Study to Investigate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy (Carboplatin-Nanoparticle Albumin Bound (Nab) Paclitaxel) in Patients With Stage IIIB/IIIC or IV NSCLC

Who this might be right for
Squamous Non Small Cell Lung Cancer
Shanghai Henlius Biotech 537
Testing effectiveness (Phase 2)Study completedNCT00387322
What this trial is testing

Pemetrexed Disodium and Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors

Who this might be right for
Lung CancerUnspecified Adult Solid Tumor, Protocol Specific
University of California, Davis 42
Testing effectiveness (Phase 2)UnknownNCT01624051
What this trial is testing

A Study Comparing Chemotherapy Dosing Based on Either Standard Body Surface Area or Lean Body Mass in Patients With Advanced Lung Cancer

Who this might be right for
Lung Cancer
AHS Cancer Control Alberta 144
Testing effectiveness (Phase 2)Study completedNCT03735680
What this trial is testing

Evaluate ONM-100, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer

Who this might be right for
Breast CancerHead and Neck Squamous Cell CarcinomaColorectal Cancer+4 more
OncoNano Medicine, Inc. 30
Testing effectiveness (Phase 2)Study completedNCT00994123
What this trial is testing

MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Merrimack Pharmaceuticals 162
Testing effectiveness (Phase 2)UnknownNCT06018688
What this trial is testing

Osimertinib Combined With Aspirin Neoadjuvant Therapy for Resectable EGFR Mutated NSCLC Patients.

Who this might be right for
Non Small Cell Lung CancerEGFR Gene Mutation
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 44
Post-approval studies (Phase 4)Study completedNCT04416633
What this trial is testing

Study to Access Safety of Durvalumab in Indian Adult Patients With Locally Advanced NSCLC

Who this might be right for
Unresectable Non-small Cell Lung Cancer (NSCLC)
AstraZeneca 100
Not applicableStudy completedNCT01346280
What this trial is testing

Evaluation of Cancer Care Coordination in the National Cancer Institutes Community Cancer Center Programs

Who this might be right for
Non-Small Cell Lung Cancer (Stage III)Colon Cancer (Stage II &Amp; III)Rectal Cancer (Stage III)
National Cancer Institute (NCI) 1,079
Early research (Phase 1)UnknownNCT03274479
What this trial is testing

PBF-1129 in Patients With NSCLC

Who this might be right for
Locally Advanced or Metastatic NSCLC
Palobiofarma SL 18
Testing effectiveness (Phase 2)Study completedNCT00293280
What this trial is testing

Lomustine in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 42
Testing effectiveness (Phase 2)UnknownNCT04519983
What this trial is testing

Efficacy of SRT as Salvage Therapy in Patients With Brain Oligo-progression of EGFR-mutant Non-small Cell Lung Cancer After Failure of the Third-generation EGFR-TKIs

Who this might be right for
Lung Cancer Stage IV
Shanghai Cancer Hospital, China 40
Next Page